AU660916B2 - Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours - Google Patents

Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours

Info

Publication number
AU660916B2
AU660916B2 AU56575/90A AU5657590A AU660916B2 AU 660916 B2 AU660916 B2 AU 660916B2 AU 56575/90 A AU56575/90 A AU 56575/90A AU 5657590 A AU5657590 A AU 5657590A AU 660916 B2 AU660916 B2 AU 660916B2
Authority
AU
Australia
Prior art keywords
hydroxamate
beta
tumours
aspartic acid
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU56575/90A
Other versions
AU5657590A (en
Inventor
Jacques Grange
Farid Hamedi Sangsari
Nicole Thomasset
Jorge Vila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU5657590A publication Critical patent/AU5657590A/en
Application granted granted Critical
Publication of AU660916B2 publication Critical patent/AU660916B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Beta-hydroxamate D-aspartic acid as a medicine, in particular for treating infections diseases caused by retroviruses, especially those that cause AIDS, as well as for treating tumours.
AU56575/90A 1989-04-28 1990-04-27 Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours Ceased AU660916B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8905744A FR2646348A1 (en) 1989-04-28 1989-04-28 D-ASPARTIC ACID-HYDROXAMATE AS A MEDICINAL PRODUCT
FR8905744 1989-04-28
PCT/FR1990/000307 WO1990013291A1 (en) 1989-04-28 1990-04-27 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours

Publications (2)

Publication Number Publication Date
AU5657590A AU5657590A (en) 1990-11-29
AU660916B2 true AU660916B2 (en) 1995-07-13

Family

ID=9381297

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56575/90A Ceased AU660916B2 (en) 1989-04-28 1990-04-27 Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours

Country Status (11)

Country Link
EP (1) EP0470144B1 (en)
JP (1) JPH04506796A (en)
AT (1) ATE121935T1 (en)
AU (1) AU660916B2 (en)
CA (1) CA2050936A1 (en)
DE (1) DE69019148T2 (en)
DK (1) DK0470144T3 (en)
ES (1) ES2072431T3 (en)
FR (1) FR2646348A1 (en)
OA (1) OA09519A (en)
WO (1) WO1990013291A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705522A (en) * 1995-09-15 1998-01-06 Compagnie De Developpement Aguettant S.A. Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
BR112012006979A2 (en) * 2009-09-29 2016-04-05 Shiseido Co Ltd antioxidant composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0250335A1 (en) * 1986-06-19 1987-12-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Medicament and therapeutical composition for the treatment of tumours as well as for the treatment of infectious diseases caused by a virus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0250335A1 (en) * 1986-06-19 1987-12-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Medicament and therapeutical composition for the treatment of tumours as well as for the treatment of infectious diseases caused by a virus

Also Published As

Publication number Publication date
EP0470144A1 (en) 1992-02-12
OA09519A (en) 1992-11-15
AU5657590A (en) 1990-11-29
DE69019148D1 (en) 1995-06-08
ATE121935T1 (en) 1995-05-15
CA2050936A1 (en) 1990-10-29
DK0470144T3 (en) 1995-10-02
JPH04506796A (en) 1992-11-26
ES2072431T3 (en) 1995-07-16
FR2646348A1 (en) 1990-11-02
DE69019148T2 (en) 1995-08-31
FR2646348B1 (en) 1994-04-22
EP0470144B1 (en) 1995-05-03
WO1990013291A1 (en) 1990-11-15

Similar Documents

Publication Publication Date Title
AU6270286A (en) Therapeutic nucleosides
MY131388A (en) Inhibitors of hiv protease useful for the treatment of aids.
AU1685499A (en) Polypeptide, their production and use
CA2130360A1 (en) Sulfonic Acid Derivatives in the Treatment of Viral Diseases
IE900073L (en) Treatment of diseases associated with hiv infections
ZA869716B (en) Antibiotic a 40926 mannosyl aglycon
ATE78696T1 (en) MEDICINAL PREPARATION FOR THE TREATMENT OF IMMUNE DEFICIENCY.
WO1987007835A1 (en) Drug for treatment and prophylaxis of kidney and liver diseases
PT85885A (en) Process for preparing novel de-acyl a 40926 antibiotics
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
JO1589B1 (en) Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
AU660916B2 (en) Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ES2013342A6 (en) Pharmaceutical composition for preventing and treating bacterial or viral diseases.
AU5061090A (en) Aids therapy
UA41338C2 (en) Method for inhibiting retroviral infection caused by human immunodeficiency virus (hiv), method for inhibiting human immunodeficiency virus (hiv)
AU5417696A (en) Substituted tetronic acids useful for treating hiv and other retroviruses
AU2396900A (en) Treatment and prevention of hiv and other viral infections
ATE69551T1 (en) COMPOSITION FOR TREATMENT OF MALIGNANT TUMORS, ESPECIALLY IN ANIMALS.
IL124354A0 (en) Hemoregulatory compounds
GEP19991605B (en) Inhibitor, Its Obtaining and Use
MY102905A (en) Therapeutic nucleosides
BG98538A (en) Means for anti-hiv therapy